Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Non-Current Debt (2020 - 2025)

Pulmonx (LUNG) has disclosed Non-Current Debt for 6 consecutive years, with $37.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Debt changed 0.3% to $37.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $37.0 million, a 0.3% change, with the full-year FY2024 number at $34.0 million, down 3.1% from a year prior.
  • Non-Current Debt was $37.0 million for Q3 2025 at Pulmonx, roughly flat from $37.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $37.2 million in Q1 2023 to a low of $179000.0 in Q3 2021.
  • A 5-year average of $23.8 million and a median of $32.0 million in 2024 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: crashed 66.79% in 2021, then skyrocketed 9527.93% in 2022.
  • Pulmonx's Non-Current Debt stood at $179000.0 in 2021, then surged by 9527.93% to $17.2 million in 2022, then soared by 103.6% to $35.1 million in 2023, then dropped by 3.1% to $34.0 million in 2024, then rose by 8.89% to $37.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non-Current Debt are $37.0 million (Q3 2025), $37.0 million (Q2 2025), and $29.4 million (Q1 2025).